NCT05502081View on ClinicalTrials.gov

Clinical Study to Compare Efficacy and Safety of Casirivimab and Imdevimab Combination, Remdesivir and Favipravir in Hospitalized COVID-19 Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

265

Participants

Timeline

Start Date

September 2, 2022

Primary Completion Date

December 28, 2022

Study Completion Date

December 28, 2022

Conditions
COVID-19
Interventions
DRUG

Casirivimab and Imdevimab Drug Combination

antiviral Monoclonal Antibodies

DRUG

Remdesivir

antiviral drug

DRUG

Favipiravir

antiviral drug

Trial Locations (1)

050

El-gomhoria St, Al Mansurah

All Listed Sponsors
lead

Mansoura University Hospital

OTHER